Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aberrant microRNA expression in multiple myeloma.
Dimopoulos K, Gimsing P, Grønbæk K. Dimopoulos K, et al. Eur J Haematol. 2013 Aug;91(2):95-105. doi: 10.1111/ejh.12124. Epub 2013 Jun 5. Eur J Haematol. 2013. PMID: 23586898 Review.
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen HD, Asmar F, Dimopoulos K, Areškevičiūtė A, Brown P, Girkov MS, Pedersen A, Sjö LD, Heegaard S, Broholm H, Kristensen LS, Ralfkiaer E, Grønbæk K. Munch-Petersen HD, et al. Among authors: dimopoulos k. Acta Neuropathol Commun. 2016 Apr 22;4:40. doi: 10.1186/s40478-016-0307-6. Acta Neuropathol Commun. 2016. PMID: 27101868 Free PMC article.
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner.
Dimopoulos K, Søgaard Helbo A, Fibiger Munch-Petersen H, Sjö L, Christensen J, Sommer Kristensen L, Asmar F, Hermansen NEU, O'Connel C, Gimsing P, Liang G, Grønbaek K. Dimopoulos K, et al. Mol Oncol. 2018 Feb;12(2):180-195. doi: 10.1002/1878-0261.12157. Epub 2017 Dec 30. Mol Oncol. 2018. PMID: 29130642 Free PMC article.
Epigenetic therapy in hematological cancers.
Dimopoulos K, Grønbaek K. Dimopoulos K, et al. APMIS. 2019 May;127(5):316-328. doi: 10.1111/apm.12906. Epub 2019 Mar 12. APMIS. 2019. PMID: 30859683 Review.
317 results